JP2010501596A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501596A5 JP2010501596A5 JP2009525863A JP2009525863A JP2010501596A5 JP 2010501596 A5 JP2010501596 A5 JP 2010501596A5 JP 2009525863 A JP2009525863 A JP 2009525863A JP 2009525863 A JP2009525863 A JP 2009525863A JP 2010501596 A5 JP2010501596 A5 JP 2010501596A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- group
- condition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006904752A AU2006904752A0 (en) | 2006-08-31 | Uses for Antibodies | |
| PCT/AU2007/001282 WO2008025099A1 (en) | 2006-08-31 | 2007-08-31 | Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010501596A JP2010501596A (ja) | 2010-01-21 |
| JP2010501596A5 true JP2010501596A5 (cg-RX-API-DMAC10.html) | 2010-09-16 |
Family
ID=39135433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525863A Pending JP2010501596A (ja) | 2006-08-31 | 2007-08-31 | 抗体含有組成物を用いた非感染性の病状の処置および/または予防 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100297140A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2061510B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2010501596A (cg-RX-API-DMAC10.html) |
| CN (1) | CN101626784B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2007291891B2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK2061510T3 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ575918A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2008025099A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009046168A1 (en) | 2007-10-02 | 2009-04-09 | Avaxia Biologics, Inc. | Antibody therapy for use in the digestive tract |
| MX2011011376A (es) | 2009-04-27 | 2012-04-20 | Immuron Ltd | Preparacion de inmunoglobulina enriquecida con anti-lps, para utilizarse en tratamiento y/o profilaxis de un trastorno patologico. |
| JP2011026252A (ja) * | 2009-07-27 | 2011-02-10 | Kitasato Institute | 上皮成長因子受容体に対する卵黄抗体およびその用途 |
| CA2808361A1 (en) | 2010-08-17 | 2012-02-23 | Immuron Ltd. | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of inflammatory bowel disease |
| CA2818827C (en) | 2010-11-23 | 2024-02-13 | Pantheryx, Inc. | Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications |
| PH12013501137A1 (en) | 2010-12-08 | 2021-06-02 | Abbvie Stemcentrx Llc | Novel modulators and methods of use |
| WO2012098256A1 (en) * | 2011-01-21 | 2012-07-26 | Université De La Méditerranée Aix - Marseille Ii | Anti-cd146 auto-antibodies and uses thereof |
| DE102011006809A1 (de) | 2011-04-05 | 2012-10-11 | Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg | Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten |
| US20140017174A1 (en) * | 2011-11-30 | 2014-01-16 | Raja Atreya | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
| RU2016119491A (ru) | 2013-11-04 | 2017-12-11 | Пфайзер Инк. | Конъюгаты антитела к efna4 с лекарственным средством |
| RO130965A8 (ro) * | 2015-10-16 | 2017-06-30 | Romvac Company S.A. | Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului |
| US10792320B2 (en) * | 2018-03-28 | 2020-10-06 | Michael Alan Beller | Methods for treatment of bladder dysfunction |
| WO2020176637A1 (en) | 2019-02-26 | 2020-09-03 | Pantheryx, Inc. | Compositions for management of disorders of the gastrointestinal tract |
| US11319382B1 (en) | 2021-06-28 | 2022-05-03 | King Abdulaziz University | Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3911108A (en) * | 1973-02-14 | 1975-10-07 | Diamond Shamrock Corp | Process of producing bovine milk products containing specific antibodies |
| AUPN642795A0 (en) * | 1995-11-08 | 1995-11-30 | Northfield Laboratories Pty Ltd | Dairy compositions and methods of preparing same |
| WO1998014209A1 (en) * | 1996-10-02 | 1998-04-09 | Ovimmune, Inc. | Oral administration of chicken yolk antibodies to treat disease |
| AU2115799A (en) * | 1998-01-19 | 1999-08-02 | Dcv, Inc. | Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| WO1999064069A1 (en) * | 1998-06-10 | 1999-12-16 | Ophidian Pharmaceuticals, Inc. | Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| CN1163511C (zh) * | 1999-10-22 | 2004-08-25 | 徐永华 | 鸡卵黄抗白细胞介素-8抗体、制备方法及其应用 |
| CN1303889A (zh) | 1999-12-20 | 2001-07-18 | 陶氏康宁东丽硅氧烷株式会社 | 用于嵌件模塑或双模腔模塑的硅橡胶组合物 |
| JP2005298332A (ja) * | 2000-09-28 | 2005-10-27 | Shibayagi:Kk | 過剰自己抗体産生抑制物質、その製造法およびその使用方法 |
| US20050175597A1 (en) * | 2002-03-21 | 2005-08-11 | Rawlin Grant T. | Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment |
| CN1199672C (zh) | 2002-04-17 | 2005-05-04 | 李永忠 | 一套预防与治疗癌症中成药 |
| CN1377894A (zh) * | 2002-04-23 | 2002-11-06 | 郭占军 | 蛋黄抗癌抗体制备方法及其应用 |
| AU2002951409A0 (en) * | 2002-09-16 | 2002-09-26 | North Western Adelaide Health Services | Methods for regulating cancer |
| JP4264894B2 (ja) * | 2004-03-01 | 2009-05-20 | 三菱自動車工業株式会社 | エアボックス付きグローブボックス |
| WO2005090406A2 (en) * | 2004-03-12 | 2005-09-29 | Vasgene Therapeutics, Inc. | Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| CA2584804A1 (en) * | 2004-10-21 | 2006-05-04 | The Penn State Research Foundation | Eph receptor tumor biomarkers |
| CA2594636A1 (en) * | 2005-01-31 | 2006-08-10 | Genentech, Inc. | Anti-ephb2 antibodies and methods using same |
| CN101253198A (zh) | 2005-08-29 | 2008-08-27 | 独立行政法人科学技术振兴机构 | 使用鸵鸟产生的抗体及其制备方法 |
-
2007
- 2007-08-31 JP JP2009525863A patent/JP2010501596A/ja active Pending
- 2007-08-31 US US12/310,643 patent/US20100297140A1/en not_active Abandoned
- 2007-08-31 NZ NZ575918A patent/NZ575918A/en unknown
- 2007-08-31 DK DK07800240.9T patent/DK2061510T3/en active
- 2007-08-31 WO PCT/AU2007/001282 patent/WO2008025099A1/en not_active Ceased
- 2007-08-31 CN CN200780039676XA patent/CN101626784B/zh not_active Expired - Fee Related
- 2007-08-31 AU AU2007291891A patent/AU2007291891B2/en not_active Ceased
- 2007-08-31 EP EP07800240.9A patent/EP2061510B1/en not_active Not-in-force
-
2013
- 2013-06-26 US US13/927,491 patent/US8834872B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6816098B2 (ja) | 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用 | |
| Thapa et al. | Application of sol–gels for treatment of gynaecological conditions—physiological perspectives and emerging concepts in intravaginal drug delivery | |
| US10441760B2 (en) | Self-actuating chemomechanical devices for delivery and extended release of therapeutic agents in the gastrointestinal tract | |
| JP6076962B2 (ja) | 治療薬を局所送達するための感熱性を有する粘膜付着性または皮膚粘着性の浸透促進剤 | |
| EA032034B1 (ru) | Наночастицы двукратно дериватизованного хитозана и способы их получения и применения для переноса генов in vivo | |
| JP2007526248A5 (cg-RX-API-DMAC10.html) | ||
| JP2016515113A5 (cg-RX-API-DMAC10.html) | ||
| JP2010501596A (ja) | 抗体含有組成物を用いた非感染性の病状の処置および/または予防 | |
| JP2019031521A5 (cg-RX-API-DMAC10.html) | ||
| JP2010500284A5 (cg-RX-API-DMAC10.html) | ||
| WO2013177927A1 (zh) | 注射用埃索美拉唑钠冻干粉组合物及其制备方法 | |
| US11149275B2 (en) | Device and method to treat esophageal disorders | |
| CN107722115A (zh) | 一种新型重组蜂毒多肽及其制备方法和应用 | |
| TWI482632B (zh) | 醫藥用載體及使用該載體的藥物結構 | |
| CN102964335B (zh) | 一种埃索美拉唑钠化合物及其制备方法和用途 | |
| CN106474472A (zh) | 肿瘤曲妥珠单抗靶向anti‑miR‑21纳米粒子及其制备方法 | |
| WO2013177963A1 (zh) | 注射用泮托拉唑钠冻干粉组合物及其制备方法 | |
| GR20180100090A (el) | Φαρμακευτικο σκευασμα σε μορφη γελης για ασθενεις με ηωσινοφιλικη οισοφαγιτιδα | |
| Xu | BIDIRECTIONAL THERMORESPONSIVE GRIPPERS FOR MACROMOLECULAR DRUG DELIVERY | |
| AU2021349286B2 (en) | Vaccine compositions for mucosal immune response | |
| CN120643498B (zh) | 基于中药成分自载体的可溶性微针穴位敷贴及其制备方法和应用 | |
| JP2015534956A5 (cg-RX-API-DMAC10.html) | ||
| CN110917478B (zh) | 一种宫颈hpv感染用药物缓释器 | |
| JP2014118361A5 (cg-RX-API-DMAC10.html) | ||
| ES2613585B2 (es) | Partículas purificadas de polen y su uso para administrar nanosistemas |